洞察
Insights From Our Experts
Articles
From Trust to Treatment: How Culture Shapes Patient Decisions in APAC
In the diverse and dynamic Asia-Pacific (APAC) region, healthcare behaviors are shaped by more than just economics or access—they are deeply influenced by cultural values. Yet many commercial, market access, and medical affairs teams within pharmaceutical…
Reimagining Patient Health Experiences: A New Paradigm for Transforming Lives
Traditionally, the healthcare system has approached patient care, especially for those with acute conditions and rare diseases, through a lens of sympathy, problem-solving, and normalization. The focus has often been on identifying deficits and developing tools…
What’s Holding Back AI Transformation?
Takeaways from 2025 Global Digital Transformation Summit Recently, I spoke at the 2025 Global Digital Transformation Summit. The event featured executives from leading companies across the intersection of technology and innovation, and we talked about the…
Trends Shaping Direct-to-Patient in Pharma – Insights from Scott Snyder
The latest wave of artificial intelligence (AI), digital health, and Direct-to-Patient (DTP) models have the potential to drive significant innovation, transform patient experiences, and redefine business and operating models across life science companies. Estimates show that…
Uncovering the Drivers of Satisfaction for Patient Services
As the needs of patients and healthcare providers evolve, it is essential to continuously adapt support services to meet these changing demands. Dive into our latest article, featuring insights from David Frey, Kevin O’Meara, and Lee…
Case Study: Increasing Product Adoption Rate through EVERSANA’s Digital Hub Portal
Problem: Our client launched a new product in the U.S. market, but initial adoption rates were disappointingly low. Physicians, who were eager to incorporate this innovative product into their practice, hesitated to prescribe from the complexity…
Overcoming the Odds: How EVERSANA Helped a Family Navigate Their Rare Disease Journey
A Rare Diagnosis and the Start of a Family’s Courageous Journey For families navigating the complexities of a rare disease diagnosis, the path can be filled with uncertainty, challenges and moments of profound resilience. One such…
Rare Disease Care in India: A Path to Positive Impact
India’s rare disease market is on the rise, expected to grow from $2.74 billion to $6.6 billion by 2030. However, challenges such as delayed diagnoses, limited treatment accessibility and underutilized government funds continue to impact patient…
Trends Shaping Direct to Patient in Pharma
Direct-to-patient (DTP) models are being utilized more and more in recent years. While this provides pharma companies with new opportunities to reach patient populations, it also creates new complications that they need to find solutions for.…
Think Tank 2025 Pharma Forecast: What Lies Ahead for the Industry in 2025?
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of emerging technologies, regulatory shifts, personalized medicine, and lessons from recent global crises. Together, these trends will redefine the pharmaceutical landscape,…